Assessing Surfactant Use in Preterm Infants to Measure NICU Quality
Author Information
Author(s): Heather C Kaplan, Scott A Lorch, Jennifer Pinto-Martin, Mary Putt, Jeffrey H Silber
Primary Institution: Cincinnati Children's Hospital Medical Center
Hypothesis
Is surfactant use in infants 30 to 34 weeks' gestation with RDS a valid measure of neonatal intensive care unit quality?
Conclusion
Surfactant use in infants with RDS shows significant variation across hospitals, indicating potential as a quality measure, but challenges in measurement and adjustment remain.
Supporting Evidence
- 46% of infants in the study received surfactant.
- Surfactant use varied significantly across hospitals.
- Increased admissions of extremely low birth weight infants were linked to higher surfactant use.
- The correlation between surfactant use and in-hospital mortality was 0.37.
Takeaway
This study looked at how often preterm babies get a treatment called surfactant to see if it shows how good the hospital is at taking care of them.
Methodology
Data was collected from 16 hospitals on infants with RDS, analyzing surfactant use and comparing it with mortality rates.
Potential Biases
Potential coding errors in RDS diagnosis and variations in care prior to transfer may introduce bias.
Limitations
Challenges included defining RDS using administrative data and adjusting for severity of illness.
Participant Demographics
Mean gestational age was 32.2 weeks; 57.8% were male and 70.8% were white.
Statistical Information
P-Value
0.051
Confidence Interval
95% CI 1.02-3.19
Statistical Significance
p = 0.051
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website